Invirsa

Invirsa develops a molecule that promotes ocular DNA repair and the innate immune response to infection and injury.

Invirsa is a business in biotechnology, health care, pharmaceutical, therapeutics based in Great Lakes, Midwestern US, founded in 2016.

Its activity falls under biotechnology, health care, pharmaceutical, therapeutics; the profile below is assembled from public directory data.

Great Lakes, Midwestern US is where the company is located.

It is recorded at the Series_B stage.

The company reports a headcount in the c_00001_00010 range.

Public records show total funding of about $16.1M.

Website: invirsa.com